Investigating emerging infectious diseases and developing medical countermeasures
Practices Core
This study is all about figuring out how new infectious diseases develop and spread, so we can create better treatments and be ready for future outbreaks, and it's being done by a team of experts in a safe lab.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10910183 on NIH RePORTER |
What this research studies
This research focuses on understanding how emerging infectious diseases evolve and spread between hosts. It aims to study the pathogenesis of these diseases and accelerate the development of new medical interventions to prepare for potential pandemics. The work is conducted in a specialized biosafety level-3 laboratory, ensuring a safe environment for handling dangerous pathogens. A collaborative team of infection biologists and clinicians will work together to address biological threats.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk of exposure to emerging infectious diseases or those involved in public health and safety.
Not a fit: Patients with established infectious diseases that are not classified as emerging or those not at risk of exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments and preventive measures against emerging infectious diseases.
How similar studies have performed: Previous research in similar biocontainment settings has shown success in developing interventions for infectious diseases, indicating a promising approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Duprex, William Paul — University of Pittsburgh at Pittsburgh
- Study coordinator: Duprex, William Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.